| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $120K | +160.4% |
| R&D Expense | $3.5M | +381.9% |
| SG&A Expense | $15.6M | -39.0% |
| Operating Income | -$19.0M | +27.9% |
| Net Income | -$18.5M | +58.3% |
| EPS (Basic) | -$5.11 | +86.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.7M | -92.0% |
| Short-term Investments | $13.1M | — |
| Accounts Receivable | $16K | +220.0% |
| Current Assets | $15.1M | -29.5% |
| Total Assets | $16.4M | -26.8% |
| Current Liabilities | $440K | +21.0% |
| Total Liabilities | $603K | -29.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.9M | -76.3% |
| Capital Expenditures | $265K | +765.1% |
| Investing Cash Flow | -$13.5M | — |
| Financing Cash Flow | $21.3M | +0.0% |
| Free Cash Flow | -$6.1M | -82.6% |
| Stockholders' Equity |
| $15.8M |
| -26.7% |